Björklund, L <br/><br/>
Tirilazad mesylate increases dopaminergic neuronal survival in the in Oculo grafting model.  [electronic resource] 

 -  Experimental neurology  Nov 1997 
 - 324-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0014-4886 
<br/><br/><label>Standard No.: </label>10.1006/exnr.1997.6655  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anterior Chamber<br/>Antioxidants--administration & dosage<br/>Brain Tissue Transplantation<br/>Dopamine--analysis<br/>Dose-Response Relationship, Drug<br/>Fetal Tissue Transplantation<br/>Graft Survival--drug effects<br/>Mesencephalon--cytology<br/>Nerve Fibers--ultrastructure<br/>Neurons--chemistry<br/>Parkinson Disease--surgery<br/>Pregnatrienes--administration & dosage<br/>Rats<br/>Rats, Sprague-Dawley<br/>Transplantation, Heterotopic